High Risk Myeloproliferative Neoplasms
1 clinical trials · Condition
◉ Watch High Risk Myeloproliferative Neoplasms
| Record | Firm | Date |
|---|---|---|
| Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN (NCT07710534) | Virginia Commonwealth University | 2026-09-30 |
Track High Risk Myeloproliferative Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.